SL-2026-J23G1S
Analytical Laboratories · Prague, CZ
Certificate of Analysis
Report number
SL-2026-J23G1S
Received
13 Sep 2026
Analysed
15 Sep 2026
Client
BIOMODERNO
Sample
CJC/Ipamorelin 10mg
Manufacturer
Biomoderno.com
Batch / Lot
BM50453233
Date ordered
01 Sep 2026
Report date
15 Sep 2026
Purity
99.659%
Quantity
25CJC-1295 (mod GRF 1-29) 5.30 mg / Ipamorelin 5.11 mg

Sample description

Appearance: White Lyophilized Powder Identity: Confirmed Purity: 99.659% Net Content: 10.41 mg

Tests requested

CJC/Ipamorelin analysis

Results

TestResultSpecificationMethod
Purity99.659%HPLC-UV
Net Content25CJC-1295 (mod GRF 1-29) 5.30 mg / Ipamorelin 5.11 mgHPLC / LC-MS
IdentityCJC/Ipamorelin ConfirmedConfirmedLC-MS
Endotoxin Replicate 1Pass≤0.05 EU/mLLAL Assay
Endotoxin Replicate 2Pass≤0.05 EU/mLLAL Assay
A. Labrof
Anton Labrof · Chief Chemist
Verify this report at:
sorricolabs.com/verify
Unique Key: SL-2026-J23G1S